| EASL clinical practice guidelines: management of hepatocellular carcinoma PR Galle, A Forner, JM Llovet, V Mazzaferro, F Piscaglia, JL Raoul, ... Journal of hepatology 69 (1), 182-236, 2018 | 7093 | 2018 |
| The 2019 WHO classification of tumours of the digestive system ID Nagtegaal, RD Odze, D Klimstra, V Paradis, M Rugge, P Schirmacher, ... Histopathology 76 (2), 182, 2020 | 2968 | 2020 |
| Senescence surveillance of pre-malignant hepatocytes limits liver cancer development TW Kang, T Yevsa, N Woller, L Hoenicke, T Wuestefeld, D Dauch, ... Nature 479 (7374), 547-551, 2011 | 1634 | 2011 |
| Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ... Annals of Oncology 29, iv238-iv255, 2018 | 934 | 2018 |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 897 | 2021 |
| Most pancreatic cancer resections are R1 resections I Esposito, J Kleeff, F Bergmann, C Reiser, E Herpel, H Friess, ... Annals of surgical oncology 15, 1651-1660, 2008 | 782 | 2008 |
| Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients … SE Al-Batran, RD Hofheinz, C Pauligk, HG Kopp, GM Haag, KB Luley, ... The lancet oncology 17 (12), 1697-1708, 2016 | 756 | 2016 |
| The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma … A Warth, T Muley, M Meister, A Stenzinger, M Thomas, P Schirmacher, ... Journal of clinical oncology 30 (13), 1438-1446, 2012 | 719 | 2012 |
| Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy A Mehrabi, A Kashfi, H Fonouni, P Schemmer, BM Schmied, P Hallscheidt, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 593 | 2006 |
| Peginterferon alpha‐2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B K Wursthorn, M Lutgehetmann, M Dandri, T Volz, P Buggisch, B Zollner, ... Hepatology 44 (3), 675-684, 2006 | 593 | 2006 |
| MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma H Varnholt, U Drebber, F Schulze, I Wedemeyer, P Schirmacher, ... Hepatology 47 (4), 1223-1232, 2008 | 579 | 2008 |
| Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment S Reiss, I Rebhan, P Backes, I Romero-Brey, H Erfle, P Matula, L Kaderali, ... Cell host & microbe 9 (1), 32-45, 2011 | 557 | 2011 |
| Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation AR Choudhury, Z Ju, MW Djojosubroto, A Schienke, A Lechel, ... Nature genetics 39 (1), 99-105, 2007 | 511 | 2007 |
| An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer L Zender, W Xue, J Zuber, CP Semighini, A Krasnitz, B Ma, P Zender, ... Cell 135 (5), 852-864, 2008 | 508 | 2008 |
| Dysregulation of growth factor signaling in human hepatocellular carcinoma K Breuhahn, T Longerich, P Schirmacher Oncogene 25 (27), 3787-3800, 2006 | 507 | 2006 |
| Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy N Halama, S Michel, M Kloor, I Zoernig, A Benner, A Spille, ... Cancer research 71 (17), 5670-5677, 2011 | 484 | 2011 |
| Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development M Eißmann, T Gutschner, M Hämmerle, S Günther, M Caudron-Herger, ... RNA biology 9 (8), 1076-1087, 2012 | 434 | 2012 |
| Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas AH Scheel, M Dietel, LC Heukamp, K Jöhrens, T Kirchner, S Reu, ... Modern Pathology 29 (10), 1165-1172, 2016 | 404 | 2016 |
| Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop R Pirker, FJF Herth, KM Kerr, M Filipits, M Taron, D Gandara, FR Hirsch, ... Journal of Thoracic Oncology 5 (10), 1706-1713, 2010 | 358 | 2010 |
| Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma DF Tschaharganeh, X Chen, P Latzko, M Malz, MM Gaida, K Felix, S Ladu, ... Gastroenterology 144 (7), 1530-1542. e12, 2013 | 352 | 2013 |
